Rapport Therapeutics, Inc. (NASDAQ:RAPP) Short Interest Up 20.7% in December
Rapport Therapeutics, Inc. (NASDAQ:RAPP - Get Free Report) was the recipient of a large increase in short interest in December. As of December 31st, there was short interest totaling 2,692,137...